Ciputra Development Tbk vs Hetzer Medical Indonesia Tbk. — how do they compare? Ciputra Development Tbk trades at Rp610 (market cap 11.03T, 7.33M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp72 (market cap 114.06B, 23.06M 24h volume). The key difference: Ciputra Development Tbk is far larger — about 96.7× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (23.06M versus 7.33M). Which is the better fit depends on your goals.
| CTRA | MEDS | |
|---|---|---|
Market Cap | 11.03T | 114.06B |
Volume | 7.33M | 23.06M |
Lot | 73.27K | 230.55K |
Turnover | 4.42B | 1.68B |
Average Price | 602.8 | 72.75 |
Value | 4.42B | 1.68B |
Indicative Equilibrium Price | 610 | 72 |
Indicative Equilibrium Volume | 5.4K | 1.56K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Read more on CTRA →PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →